Semaglutide vs Tirzepatide
US$ 27.26
switching from tirzepatide to semaglutide for maintenance Tirzepatide: A Provider's Guide Could a switch from #tirzepatide
Description
In the trial that got Zepbound approved, the average person on the highest 15 mg dose lost 20.9% of their body weight over 72 weeks
Retatrutide's main side effects in trials: nausea (43%), heart rate increase of ~6.7 bpm, and dysesthesia (20.9%) at the 12 mg dose
As demand for GLP-1 weight-loss solutions grows, prescription-free alternatives are getting a lot of attention
Physician-formulated for GLP-1 users
Biopharma bigwigs Eli Lilly and Novo Nordisk are upping capacity to meet the rising demands of GLP-1 drugs.
Benefits of Treatment
